Referências

• 1 Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.J Urol 1994;151: 54-61.
• 2 Lobb-Rossini K. Erectile dysfunction and its management. Journal of Community Nursing Online 1999;13 (10):1-8.
• 3 Science Daily (online), disponivel em http://www.sciencedaily.com/releases/2007/09/070910160946.htm, acedido em Março de 2010
• 4 Aytaç, Mckinlay & Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999; 84:50-6.
• 5 Dey J, and Shepherd MD. Evaluation and treatment of erectile dysfunction with diabetes mellitus Mayo Clinic Proceedings 2002;77: 276-82
• 6 Ghezzi e tal. Erectile impotence in multiple sclerosis: a neurophysiological study , J Neurol 1995;242: 123-126 J Neurol, 1995 242 (3):123-6.
• 7 Jackson G. The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep. 2007 Nov;8(6):463-6.
• 8 Miller T. Diagnostic evaluation of erectile dysfunction. Am Fam Physician, 2000; 61:95-104.
• 9 Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator Heart.2003 Mar;89(3):251-3.
• 10 The New York Times (online),disponivel em http://www.nytimes.com/2007/02/20/health/20iht-drugs.4656560.html, acedido em Março de 2010
• 11 Jackson G, Rosen RC et al. The Second Princeton Consensus on Sexual Dysfunction and Cardiac Risk: New Guidelines for Sexual Medicine. J Sex Med 2006; 3:28-36
• 12 National Heart Lung and Blood institute Disease and conection index, (online) , disponivel em http://www.nhlbi.nih.gov/health/dci/Diseases/ms/ms_treatments.html, acedido em Março 2010
• 13 Porst H. Premature ejaculation. Urologe A 2009 Jun;48(6):663-74.
• 14 Safarinejad MR, Hosseini SY.Erectile dysfunction: clinical guidelines (2).Urol J. 2004;1(4):227-39.
• 15 Safarinejad H. Erectile Dysfunction. Clinical Guidelines (1). Urol J, 2004, 3(1):133-147
• 16 Cancer Research UK (Online), disponível em, http://info.cancerresearchuk.org/cancerstats/incidence/prevalence/index.htm,  Acedido em Março de 2010
• 17 American College of Sports Medicine (online). Physical Activity and Public health Guidelines, disponivel emhttp://www.acsm.org/AM/Template.cfm?Section=Home_Page&TEMPLATE=CM/HTMLDisplay.cfm&CONTENTID=7764, acedido em Março de 2010
• 18 European Alliance for Access to Safe Medicine (online); The Counterfeiting Superhighway, 2008, diponível em http://v35.pixelcms.com/ams/assets/312296678531/455_EAASM_counterfeiting%20report_020608.pdf, acedido em Março 2010
• 19 Jackson.Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks Int J Clin Pract 2010;N/A: 64: 413
• 20 Wespes E, Amar E, Hatzichristou D, et al. EAU guidelines on erectile dysfunction: An update European Urology 2006;49: 806-15
• 21 Resumo das caracteristicas do medicamento Cialis 10, 20 mg
• 22 Resumo das caracteristicas do medicamento Cialis 5 mg
• 23 Resumo das caracteristicas do medicamento Viagra
• 24 Resumo das caracteristicas do medicamento Levitra
• 25 Tamler R. . Diabetes, obesity, and erectile dysfunction Gend Med 2009;6 Suppl 1: 4-16
• 26 European Society for Sexual Medecine (online) .Disponível em: http://www.essm.org/patient-area/erectile_dysf.asp#q2,   acedido em Março de 2010